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ABSTRACT Protein 4.1 is an extrinsic membrane protein
that facilitates the interaction of spectrin and actin in the
erythroid membrane skeleton and exists as several structurally
related polypeptides in chickens. The ratio of protein 4.1
variants is developmentally regulated during terminal differ-
entiation of chicken erythroid and lenticular cells. To examine
the mechanisms by which multiple chicken protein 4.1 variants
are differentially expressed, we have isolated cDNA clones
specific for chicken erythroid protein 4.1. We show that a single
protein 4.1 gene gives rise to multiple 6.6-kilobase mRNAs by
differential RNA processing. Furthermore, the ratios of pro-
tein 4.1 mRNAs change during chicken embryonic erythro-
poiesis. We observe a quantitative difference in variant ratios
when protein 4.1 is synthesized in vivo or in a rabbit reticulo-
cyte lysate in vitro. Our results show that the expression of
multiple protein 4.1 polypeptides is regulated at the levels of
translation and RNA processing.
A network based on the proteins spectrin and actin lines the
cytoplasmic surface of the mammalian erythrocyte plasma
membrane and is believed to confer upon this cell membrane
its properties of strength and elasticity (1, 2). Protein 4.1
facilitates the interaction of spectrin and actin by forming a
ternary complex with these components and also has been
shown to interact directly with two intrinsic membrane
proteins, glycophorin and the anion transporter, and mem-
brane phospholipid (2). Protein 4.1, therefore, plays a key
role in the maintenance of the membrane skeleton. Protein
4.1 exists as a set of structurally related polypeptides in avian
erythroid cells (3). In chicken erythrocytes, seven major
protein 4.1 variants of 77, 87, 100, 115, 150, 160, and 175 kDa
are expressed, with the 100- and 115-kDa polypeptides found
in highest abundance (3, 4). However, in immature mitotic
erythroblasts, the 77- and 87-kDa protein 4.1 variants pre-
dominate, and as the cells undergo terminal differentiation,
the 100- and 115-kDa forms are found at higher levels (4, 5).
Protein 4.1 and protein 4.1 analogues also have been localized
in nonerythroid tissues (3, 4, 6-11).
To define the mechanism(s) by which multiple protein 4.1
variants are generated, we have isolated cDNA clones
encoding chicken protein 4.1. Partial DNA sequence analysis
demonstrates 86% homology with human protein 4.1 cDNA
sequences (12) over a 270-base-pair portion of a chicken
protein 4.1 cDNA. We find that the gene encoding protein 4.1
exists as a single copy in the haploid chicken genome and
gives rise to one 6.6-kilobase (kb) size-class of RNA. By S1
nuclease mapping experiments, we demonstrate that this
single size-class RNA consists of multiple, distinct mRNAs,
whose expression is developmentally regulated during chick-
en embryonic erythropoiesis. Hence, a heterogeneity of
protein 4.1 mRNAs appears to underlie the diversity of
protein 4.1 polypeptides. A comparison of protein 4.1 poly-
peptides synthesized in vitro and in vivo shows that the
relative abundance of protein 4.1 variants is further regulated
at the translational level.
MATERIALS AND METHODS
Isolation of Protein 4.1 cDNAs. Protein 4.1-specific cDNAs
were isolated from a Xgtll expression library constructed
from 14- to 15-day chicken embryo erythroid poly(A)+ RNA
("M" library of ref. 13). The library was screened with a
protein 4.1-specific antiserum (3), and positive plaques were
isolated and rescreened several times, as described (13).
Complementary DNA inserts of candidate protein 4.1 clones
were isolated from EcoRI-digested recombinant phage DNA
and inserted into pT7SP6 (a gift of V. Axelrod, Columbia
University) (14) or ml3mpl9. DNA sequence analysis was
performed by the dideoxynucleotide chain-termination pro-
cedure (15).
RNA Preparation. Total cellular or cytoplasmic poly(A)+
RNA was prepared from chicken embryonic erythroid cells
as described (13). To enrich for protein 4.1 mRNA, cytoplas-
mic poly(A)+ RNA was fractionated on a formamide/sucrose
gradient, as described (13). Fractions were collected, RNA
was concentrated by ethanol precipitation, and fractions
containing protein 4.1 translational activity in a rabbit retic-
ulocyte lysate (16) were pooled.
In Vitro Translation and Hybridization-Selected Transla-
tion. Poly(A)+ RNA was translated in vitro for 90 min at 30°C
in a high-activity nuclease-treated rabbit reticulocyte lysate
containing [35S]methionine (13, 16). Complete translation
reactions or immunoprecipitates using a protein 4.1 antise-
rum (3) were resolved on 12.5% polyacrylamide/NaDodSO4
gels (17). For an in vivo protein 4.1 standard, 15-day chicken
embryo erythroid cells were metabolically labeled with
[35S]methionine for 30 min at 37°C, fractionated with Triton
X-100, and immunoprecipitated with the protein 4.1 antise-
rum, as described (3). Labeled protein bands were visualized
by fluorography of gels impregnated with 2,5-diphenyloxa-
zole (18). Plasmid DNA was bound to nitrocellulose and
subjected to positive hybridization-selected translation, as
described (13, 19). RNA selected from 10 ,ug of gradient-
enriched poly(A)+ RNA was translated in 15 A1l of rabbit
reticulocyte lysate.
DNA and RNA Analysis. DNA was digested with restriction
endonucleases, electrophoresed, blotted to nitrocellulose,
and protein 4.1 sequences were detected with 32P-labeled
nick-translated cDNA inserts (20, 21). RNA blots were as
described (22, 23). S1 nuclease protection (24) of a protein 4.1
Abbreviation: nt, nucleotide(s).
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cDNA was performed by hybridizing RNA with an end-
labeled 3.1-kb Xho I-Pvu I fragment ofpFPO20, as described
in the legend of Fig. 5.
RESULTS
Isolation of Chicken Protein 4.1 cDNAs. We identified
cDNA clones coding for protein 4.1 from a Xgtll expression
library (13) by screening with an antiserum specific for
chicken protein 4.1 (3). DNA sequence analysis of the 270
nucleotides (nt) at the 5' end of one cDNA, pFPO20, reveals
86% nucleotide homology with a human reticulocyte protein
4.1 cDNA (12), rendering 98% amino acid sequence conser-
vation from chicken to human protein 4.1 in this region (Fig.
la). A restriction endonuclease map of representative protein
4.1 cDNAs is shown in Fig. lb; we conclude from the above
data that the cDNAs shown are specific for protein 4.1.
In Vitro Translation of Chicken Protein 4.1 and Positive
Hybridization-Selected Translation. To examine the mRNA(s)
encoding the protein 4.1 polypeptides, we analyzed [35S]me-
thionine-labeled translation products synthesized in a rabbit
reticulocyte lysate (13, 16), using cytoplasmic poly(A)+ RNA
isolated from circulating erythroid cells of 15-day chicken
embryos. The seven major protein 4.1 variants of 77, 87, 100,
115, 160, and 175 kDa were immunoprecipitated from the in
vitro translation mixture; the 160- and 175-kDa polypeptides
were in greatest abundance (Fig. 2a, lane 2). However, when
protein 4.1 was immunoprecipitated from cytoskeletal ex-
tracts of 15-day embryo erythroid cells metabolically labeled
with [35S]methionine, the 100- and 115-kDa polypeptides
were the predominant forms, and the 77-, 87-, 150-, 160-, and
175-kDa variants were found in lower relative amounts (3-5)
(see Fig. 2 a, lane 1, and b, lane 8). As the protein 4.1
polypeptides are rapidly stabilized in the membrane skeleton
with equivalent efficiencies shortly after their synthesis
(3-5), the pattern of protein 4.1 variants identified after
labeling in vivo, shown in Fig. 2, closely approximated their
ratios of synthesis as well as the steady-state ratios (3). The
relative rates of synthesis of protein 4.1 variants in vitro and
in vivo, therefore, differ significantly.
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Protein 4.1 was a minor in vitro translation product and was
not identifiable in the total translation reaction mixture
(compare Fig. 2a, lanes 2 and 3). To increase the relative
abundance of protein 4.1 mRNA, we fractionated 15-day
embryo erythroid poly(A)+ RNA on a denaturing 4-20%
sucrose gradient and pooled RNA fractions with protein 4.1
translational activity. Translation of this material in vitro
showed that this preparation was substantially depleted of
globin mRNA (Fig. 2b, lane 1; compare with Fig. 2a, lane 3)
and directed the translation of the protein 4.1 polypeptides
(Fig. 2b, lane 2). The immunoprecipitated 87-, 100-, and
115-kDa variants were more visible over the reduced back-
ground from the gradient-enriched RNA translation mixture
than from the unfractionated RNA translation mixture (Fig.
2a, lane 2). We, therefore, used gradient-enriched RNA for
subsequent hybridization-selected translation experiments.
We performed hybridization-selected translations to fur-
ther determine the structural relatedness of the protein 4.1
polypeptides. Fig. 2b shows that a representative cDNA,
pFPO2a, hybridized to RNA that directed the synthesis of
protein 4.1 polypeptides (lane 5). In contrast, the plasmid
vector alone did not hybridize to any detectable protein 4.1
RNA (lane 4). The hybridization-selected translation prod-
ucts shown in lane 5 were specifically immunoprecipitated by
an anti-protein 4.1 antiserum (lane 7), whereas no protein 4.1
translation products were immunoprecipitated from the plas-
mid vector-mediated translation reaction mixture (lane 6).
Positive hybridization-selected translation was repeated us-
ing pFPO2a, pFPO2b, and pFPO20, with results similar to
those shown in Fig. 2 (data not shown). We conclude that the
cDNAs described here, together representing =3.5 kb, or
55% of protein 4.1 mRNA (see below), are complementary to
the mRNA(s) encoding all the major protein 4.1 variants
found in 15-day embryo erythroid RNA.
Representation of Protein 4.1 Sequences in the Chicken
Genome. Blot analysis of chicken genomic DNA using
32P-labeled protein 4.1 cDNA probes shows that the multiple
protein 4.1 polypeptides are encoded by a single gene (Fig. 3).
pFPO2a hybridized to several genomic DNA bands generat-
ed by digestion with BamHI, HindIII, EcoRI, or Xba I (Fig.
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FIG. 1. Protein 4.1 cDNAs. (a) DNA sequence analysis of the 270
nt at the 5' end ofpFPO20. Top row: sequence of a human protein 4.1
cDNAfrom nt 1324 to nt 1593, according to Conboy et al. (12). Middle
row: sequence ofpFPO20. Dots indicate nonhomologous nucleotides.
Bottom row: Amino acid sequence derived from the chicken protein
4.1 cDNA. Nonhomologous human protein 4.1 residues are indicated
in parentheses. (b) Restriction endonuclease map of protein 4.1
cDNAs. pFPO2a and pFPO2b were isolated from the sanme Xgtll
recombinant (XFPO-2). EcoRI sites in parentheses are from synthetic
linkers, whereas the EcoRI site shared by pFPO2a and pFPO2b
occurs naturally. The direction of transcription of pFPO2a and
pFPO2b was determined by their orientation within the f-galacto-
sidase gene of Xgtll (25). pFPO20 was isolated subsequent to
back-screening of the X cDNA library with the pFPO2a insert.
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FIG. 2. Synthesis of protein 4.1 in vivo and in vitro and identi-
fication of protein 4.1-specific cDNAs. (a) NaDodSO4/polyacrylam-
ide gel electrophoretic analysis of protein 4.1 synthesis. Lanes: 1,
immunoprecipitate of protein 4.1 from cytoskeletal extracts of 15-day
embryo erythroid cells labeled in vivo; 2, immunoprecipitate from 10
1ul of rabbit reticulocyte lysate in which 15-day embryo erythroid
cytoplasmic poly(A)+ RNA was translated; 3, 1 A.l of the complete
in vitro translation reaction mixture used in lane 2. The three high
molecular weight bands in lane 3 are ankyrin, a-spectrin, and
,/-spectrin, in descending order. Bars indicate positions of protein 4.1
variants (from top to bottom): 175 kDa, 160 kDa, 150 kDa, 115 kDa,
100 kDa, 87 kDa, and 77 kDa. The asterisk marks the position of the
70-kDa heat shock protein, which is a major translation product of
15-day embryo erythroid RNA and which is immunoprecipitated
nonspecifically from the in vitro translation reaction mixtures. Lanes
1 and 2 were fluorographed for 8 days, whereas lane 3 was exposed
for 16 hr. (b) NaDodSO4/polyacrylamide gel analysis of gradient-
enriched erythroid poly(A)+ RNA translation products and hybrid-
ization-selected translation products. Lanes: 1, 0.5 1l of an in vitro
translation of gradient-enriched 15-day embryo erythroid poly(A)+
RNA; 2, immunoprecipitate from 10 Al. of the in vitro translation
reaction mixture shown in lane 1; 3, endogenous translational activity
from S ,ul of lysate with no added RNA; 4, products of hybridization-
selected translation using plasmid vector (5 ,ul of a 15-jl reaction
mixture); 5, products of hybridization-selected translation mediated
by pFPO2a (5 Al); 6 and 7, protein 4.1-specific immunoprecipitate
from 10 ,ul of lysate shown in lanes 4 and 5, respectively; 8, im-
munoprecipitate of metabolically-labeled protein 4.1, as in a, lane 1.
Bars indicate positions ofprotein 4.1 polypeptides, as in a. Lanes 1-8
represent consecutive lanes from the same gel, but were fluoro-
graphed for 1 day (lane 1), 3 days (lanes 2-5), or 6 days (lanes 6-8).
3a). When the 1.7-kb EcoRI-BamHI 5' end fragment or the
0.7-kb BamHI-EcoRI 3' end fragment of pFPO2a was used
as probe (see Fig. la), each hybridized to a subset of the
genomic bands obtained with the entire cDNA insert (Fig. 3
b and c). A similar hybridization using pFPO2b as probe
identified the same BamHI, HindIII, and Xba I genomic
fragments detected by the pFPO2a 3' probe (Fig. 3 c and d,
lanes 1-3), but since pFPO2a and pFPO2b share a common
terminal EcoRI site, pFPO2b hybridized to a genoinic EcoRI
fragment that was not detected by pFPO2a (Fig. 3 a-d, lanes
4). The hybridization patterns shown in Fig. 3 a-d, in
conjunction with a preliminary analysis of overlapping pro-
tein 4.1 genomic DNA phage recombinants (unpublished
observations), indicate that the multiple bands detected in
protein 4.1 genomic DNA blots are contiguous; pFPO2a and
pFPO2b hybridize to overlapping cloned genomic sequences
FIG. 3. Blot analysis of chicken genomic DNA using protein 4.1
cDNA probes. (a-d) One microgram of chicken liver DNA was
digested with BamHI (lane 1), HindI11 (lane 2), EcoRI (Lane 3), or
Xba I (lane 4), electrophoresed on a 0.9% agarose gel, and blotted to
nitrocellulose. Blots were hybridized to the following 32P-labeled
nick-translated cDNA sequences. (a) pFPO2a insert. (b) The 1.7-kb
pFPO2a 5' EcoRI-BamHI fragment. (c) The 0.7-kb pFPO2a 3'
BamHI-EcoRI fragment. (d) pFPO2b insert. The autoradiograms in
a-d were from adjacent strips of nitrocellulose blotted to the same
gel. The positions ofX DNA digested with HindIII are shown (23, 9.4,
6.6, 2.3, 2.0, and 0.56 kb). (e) Determination of protein 4.1 gene copy
number. A recombinant phage, X4.1-19, containing chicken protein
4.1 gene sequences was isolated from aX Charon 4A genonlic library
(26) and used to quantitate protein 4.1 DNA hybridization. Chicken
liver DNA (1.0 Atg and 0.5 A.g) and X 4.1-19 DNA were digested with
EcoRI, separated on a 0.9%o agarose gel, blotted to nitrocellulose,
and hybridized to 32P-labeled pFPO2a. The 1.8-kb EcoRI band
(arrowhead) was used to calibrate the hybridization signals. Lanes:
1, 1.0 Aug of chicken liver DNA; 2, 0.5 ,Ag of chicken liver DNA; 1-8,
X4.1-19 DNA corresponding to 0.25, 0.5, 1.0, 2.0, and 4.0 copies per
haploid genome (C value = 1.5 pg) per Aug of chicken DNA,
respectively. Bars denote X HindIll-digested DNA size markers.
spanning over 40 kb (unpublished observations). To deter-
mine the copy number of the protein 4.1 gene(s) in the
chicken genome, known amounts of genomic DNA or DNA
of a protein 4.1 genomic clone, X4.1-19, were digested with
EcoRI, and the relative hybridization of the 1.8-kb EcoRI
fragment (an internal restriction fragment in the X4.1-19
insert; data not shown) with 32P-labeled pFP02a was used to
determine gene copy number (see Fig. 3 legend). The auto-
radiogram of Fig. 3e shows that the 1.8-kb EcoRI band
detected (arrowhead) was found at one copy per haploid
genome (compare lanes 1 and 6 or lanes 2 and 5). Since
pFP02a is complementary to RNA(s) encoding all the major
protein 4.1 polypeptides (Fig. 2b, lanes 5 and 7), we conclude
that multiple protein 4.1 variants arise from a single gene.
Multiple Protein 4.1 mRNAs of Indistinguishable Sizes
Encode Multiple Chicken Protein 4.1 Polypeptides. The ex-
periments shown in Figs. 2 and 3 suggest that multiple protein
4.1 variants arise by translationally regulated expression of
one of several mRNA(s) encoded by a single gene. RNA blot
analysis of gradient-enriched 15-day embryo erythroid
poly(A)+ RNA using 32P-labeled pFP02a as probe revealed
a single major 6.6-kb RNA (Fig. 4b, lane I). Several minor
bands smaller than the 6.6-kb RNA were also detected amid
a trail of degradation (Fig. 4b, lane I), in a pattern similar to
that found in unfractionated poly(A)+ RNA (data not shown).
To determine if these minor species were protein 4.1 mRNAs
or stable degradation intermediates, we separated the gradi-
ent-enriched RNA on a preparative methylmercury hydrox-
ide agarose gel and analyzed gel-fractionated RNA by in vitro
translation or by RNA blot analysis (Fig. 4). The autoradi-
ograms of Fig. 4 a and b show that translation of each major
protein 4.1 variant cofractionates in gel slices 4-7 (Fig. 4a),
which corresponds to the major 6.6-kb protein 4.1 RNA peak
(Fig. 4b). Within this peak, the ratios of the protein 4.1
polypeptides remained constant from fraction to fraction.
The resolution of this experiment was sufficient to separate
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the streak of degraded protein 4.1 RNA, as well as the minor
RNA species, from the protein 4.1 mRNA peak in slices 4-7.
Hence, multiple protein 4.1 polypeptides are derived from a
single mRNA size-class.
Although a single size of mRNA appeared to give rise to
multiple protein 4.1 products, we could not rule out the
existence of multiple protein 4.1 mRNAs with indistinguish-
able electrophoretic mobilities. We, therefore, performed Si
nuclease digestions on hybrids formed between erythroid
protein 4.1 RNA and an end-labeled protein 4.1 cDNA. For
this purpose, a probe was prepared that consisted of a
pFPO20 fragment end-labeled at the Xho I site (see Fig. la).
Fig. 5, lane 2, shows that the pFPO20 probe was protected by
four distinct RNA species from erythroid cells of 15-day
chicken embryos. The 1700-nt protected fragment identifies
an RNA species complementary to pFPO20 from the Xho I
site to the 3' terminus of the insert. Additional fragments are
present at 730 nt, 580 nt, and 470 nt (barely visible in this
exposure; see below) and represent RNAs that are derived
from DNA containing this Xho I site, but are divergent 730,
580, and 470 nt downstream. Si nuclease analysis of RNA
fractionated on the same methylmercury hydroxide agarose
gel described in Fig. 4 demonstrates that the multiple protein
4.1 RNAs coelectrophorese at 6.6 kb (Fig. 4c), precluding the
possibility that the multiplicity of protected fragments arose
from RNA precursors or degradation products. A greater
heterogeneity of protein 4.1 mRNA may well exist, as other
putative RNAs that do not contain sequences both comple-
mentary to and continuous with the Xho I site within this
1.7-kb cDNA would not be detected.
Expression of Multiple Protein 4.1 mRNAs Is Developmen-
tally Regulated. Circulating erythroid cells of 4-day embryos
are "early" mitotic erythroblasts of the primitive series,
1 2 3 4
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FIG. 4. Fractionation of 15-day embryo erythroid RNA on a
methylmercury hydroxide agarose gel and analysis by in vitro
translation, RNA blotting, and S1 nuclease protection. Gradient-
enriched poly(A)+ RNA was electrophoresed in the presence of
methylmercury hydroxide (27) on a preparative 0.9% low gelling
temperature agarose gel. The gel was sliced in 0.5-mm-thick sections
perpendicular to the axis of electrophoresis, and RNA was isolated
as described (22). (a) In vitro translation of fractionated RNA. RNA
was translated in a rabbit reticulocyte lysate containing [35S]methi-
onine, immunoprecipitated with protein 4.1 antiserum, and analyzed
on a 12.5% polyacrylamide/NaDodSO4 gel. Lanes: C, immunopre-
cipitate of protein 4.1 from 15-day embryo erythroid cells labeled
with [35S]methionine; I, immunoprecipitation from reticulocyte ly-
sate in which gradient-enriched poly(A)+ RNA ("input") was trans-
lated; 1_15, immunoprecipitates from translation reaction mixtures
of fractionated RNA from gel slices 1-15, respectively. Bars indicate
175, 160, 150, 115, 100, and 87 kDa protein 4.1 variants. (b) RNA blot
of fractionated RNA. RNA was electrophoresed in the presence of
formaldehyde, blotted to nitrocellulose, and probed with 32P-labeled
pFPO2a cDNA insert. Lanes: I, gradient-enriched RNA ("input");
1-15, RNA from slices 1-15. (c) S1 nuclease analysis of fractionated
RNA. S1 nuclease mapping was performed using a 32P-end-labeled
pFPO20 cDNA probe (see Fig. 5 legend). Protected fragments were
separated on a 1.5-mm-thick 7 M urea/5% polyacrylamide gel.
tRNA, 32P-labeled DNA protected after incubation with tRNA. Lane
I, fragments protected by gradient-enriched poly(A)+ RNA ("in-
put"). Lanes 2-9, fragments protected by RNA in slices 2-9.
- 730 nt
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FIG. 5. S1 nuclease protection of protein 4.1 cDNA by chicken
erythroid RNA. pFPO20 was cleaved with Xho I and end-labeled by
filling out with DNA polymerase I large fragment in the presence of
[a-32P]dNTPs (see Fig. lb), digested with Pvu I, and the 3.1-kb
fragment containing 1.7-kb insert plus 1.4-kb vector sequences was
isolated and hybridized with RNA in 80% (vol/vol) formamide, 40
mM Pipes (pH 6.4), 0.4 M NaCl, 1 mM EDTA at 50TC for 15 hr.
Samples were digested with S1 nuclease (24), and fragments were
resolved on 0.3-mm-thick denaturing 7 M prea/5% polyacrylamide
gels. Lanes: 1, undigested probe; 2, fragments protected by 2 /Ig of
cytoplasmic poly(A)+ RNA of 15-day embryo erythroid cells; 3,
fragments protected by 2 gg of totg cellular poly(A)I RNA of 4-day
embryo erythroid cells; 4, S1 nuclease digestion following hybrid-
ization with 2 ,ug of tRNA. Bars indicate mobilities of end-labeled
DNA markers (1856, 1060, 929, 622, 527, 404, 383, and 309 nt).
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whereas circulating erythroid cells of 15-day embryos are
"late" postmitotic definitive series cells (36). The pattern of
protein 4.1 variant expression in embryonic erythroid cells
changes during ontogeny as well as within the primitive series
and definitive series lineages (4). To compare a "late"
pattern of protein 4.1 mRNA expression (Fig. 5, lane 2) with
a pattern from "early" cells, we performed S1 nuclease
analysis on RNA from 4-day embryos. Using the 32P-end-
labeled probe described above, we found protection of only
the 470-nt and 580-nt fragments by the 4-day embryo
erythroid RNA (Fig. 5, lane 3). Blot analysis of this RNA
detects a single 6.6-kb protein 4.1-specific band (data not
shown). We interpret the results described above to indicate
that the generation of multiple protein 4.1 mRNAs is devel-
opmentally regulated.
DISCUSSION
We have examined the mechanisms by which multiple
chicken protein 4.1 polypeptides are generated, using cloned
cDNA probes specific for protein 4.1. Our protein 4.1 cDNAs
are complementary to RNAs encoding all the major chicken
erythroid protein 4.1 polypeptides, as shown by hybridiza-
tion-selected translations. Quantitative genomic DNA blot-
ting reveals that multiple protein 4.1 variants arise from a
single gene. By RNA blot analysis and S1 nuclease mapping,
we have determined that the single protein 4.1 gene generates
multiple mRNAs with indistinguishable sizes. The observa-
tion of multiple 6.6-kb mRNAs exhibiting sequence discon-
tinuities at distances of up to -1 kb apart indicates that
alternative pathways of pre-mRNA splicing (e.g., see refs.
28-30) play a key, but not necessarily exclusive, role in the
genesis of multiple protein 4.1 mRNAs. Different sites of
transcription initiation as well as termination and/or tran-
script cleavage and polyadenylylation may also occur and
indeed may determine the selection of splicing patterns, as
shown for other transcription units (e.g., see refs. 31-33).
In this study we show that the differential expression of
multiple protein 4.1 mRNAs is developmentally regulated, as
the mRNAs detected switch from "early" primitive cells to
"late" definitive cells. This switch is paralleled by changes in
protein 4.1 polypeptide synthesis and accumulation (4).
Translational and/or cotranslational processes also regulate
the pattern of protein 4.1 expression, as demonstrated by the
quantitative difference in protein 4.1 polypeptide synthesis in
vivo and in vitro. The relative amounts of protein 4.1 variants
may be controlled by preferential translation of certain
protein 4.1 mRNAs. Alternatively, limited cotranslational or
rapid posttranslational processing of the larger protein 4.1
polypeptides may give rise to the smaller variants (see refs.
3 and 5), Hence, although expression of protein 4.1 polypep-
tides is specified initially at the mRNA level by RNA
processing, the relative abundance or perhaps even the
presence or absence of each variant is further determined by
translational or cotranslational mechanisms.
Our data regarding the expression of multiple protein 4.1
mRNAs from a single gene may be applicable to the observed
occurrence of protein 4.1 and protein 4.1 analogues in
nonerythroid tissues (3, 4, 6-9, 11). For example, in develop-
ing chicken lens, protein 4.1 variants similar to those found
in chicken erythroid cells are present (3, 4). A 6.6-kb protein
4.1 mRNA is detected in chicken lens by RNA blotting (data
not shown), suggesting that lens protein 4.1 is specified by the
same gene that encodes erythroid protein 4.1. The signifi-
cance of producing multiple protein 4.1 mRNAs and poly-
peptides in a developmentally regulated and tissue-specific
manner remains to be determined. It is possible that differ-
ential splicing of protein 4.1 exons facilitates the expression
of alternative functional domains, which would affect or
mediate the interactions of protein 4.1 with other membrane
skeletal components. Future studies employing full-length
protein 4.1 cDNAs should facilitate our understanding of
both the structural and regulatory features of the differential
expression of multiple protein 4.1 mRNAs and polypeptides.
Mammalian erythroid protein 4.1 exists as two structurally
related polypeptides with molecular masses of 80 kDa (4. la)
and 78 kDa (4.lb) (34, 35); protein 4.la and 4.lb differ at their
carboxyl termini but appear to be functionally equivalent
(35). Mammalian lens generally expresses a minor 125- to
145-kDa protein 4.1-related polypeptide in addition to the
protein 4.la/b doublet (3, 6, 11). Hence, mammalian protein
4.1 is expressed as a number of related variants, but the
extent of heterogeneity is less, or perhaps more subtle, than
that found in avian species.
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